JP2016510315A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510315A5 JP2016510315A5 JP2015548630A JP2015548630A JP2016510315A5 JP 2016510315 A5 JP2016510315 A5 JP 2016510315A5 JP 2015548630 A JP2015548630 A JP 2015548630A JP 2015548630 A JP2015548630 A JP 2015548630A JP 2016510315 A5 JP2016510315 A5 JP 2016510315A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- combination according
- tissue factor
- fusion protein
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12198839.8 | 2012-12-21 | ||
| EP12198839.8A EP2745852A1 (en) | 2012-12-21 | 2012-12-21 | Sealant compositions |
| PCT/EP2013/077674 WO2014096354A1 (en) | 2012-12-21 | 2013-12-20 | Sealant compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510315A JP2016510315A (ja) | 2016-04-07 |
| JP2016510315A5 true JP2016510315A5 (https=) | 2017-02-09 |
| JP6518591B2 JP6518591B2 (ja) | 2019-05-22 |
Family
ID=47563088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548630A Expired - Fee Related JP6518591B2 (ja) | 2012-12-21 | 2013-12-20 | シーラント組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20160082145A1 (https=) |
| EP (2) | EP2745852A1 (https=) |
| JP (1) | JP6518591B2 (https=) |
| CN (1) | CN104955493A (https=) |
| AU (1) | AU2013366544B2 (https=) |
| BR (1) | BR112015014926B1 (https=) |
| CY (1) | CY1118938T1 (https=) |
| DK (1) | DK2934612T3 (https=) |
| ES (1) | ES2627053T3 (https=) |
| HR (1) | HRP20170880T1 (https=) |
| HU (1) | HUE034649T2 (https=) |
| LT (1) | LT2934612T (https=) |
| MX (1) | MX361222B (https=) |
| PL (1) | PL2934612T3 (https=) |
| PT (1) | PT2934612T (https=) |
| SI (1) | SI2934612T1 (https=) |
| WO (1) | WO2014096354A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109010906B (zh) * | 2018-08-16 | 2021-05-14 | 陈明远 | 一种促进术后伤口局部止血及促进术后创面上皮化的生物胶水及其工作方法 |
| US11666682B2 (en) * | 2020-08-31 | 2023-06-06 | Ethicon, Inc. | Method of stopping CSF leaks and apparatus therefor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0748215B1 (en) * | 1994-02-17 | 2003-05-28 | New York Blood Center, Inc. | Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| EP0885020A1 (en) * | 1996-02-20 | 1998-12-23 | Cohesion Corporation | Tissue sealant compositions and methods of use thereof |
| AU9786198A (en) * | 1997-10-10 | 1999-05-03 | University Of Virginia | Use of fibrin sealant to maintain hemostasis, lymphostasis and prevent local accumulation of body fluids |
| EP1749536A1 (en) * | 2005-08-03 | 2007-02-07 | Thrombotargets Europe, S.L. | Activated factor X stimulants as new antihemorrhagic agents for topical use |
| EP1939218A1 (en) | 2006-12-29 | 2008-07-02 | Thrombotargets Europe, S.L. | Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
| EP2145695A1 (de) | 2008-07-14 | 2010-01-20 | Sika Technology AG | Vorrichtung zur Klebstoffapplikation |
| EP2380905A1 (en) | 2010-04-19 | 2011-10-26 | Thrombotargets Europe, S.L. | Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
-
2012
- 2012-12-21 EP EP12198839.8A patent/EP2745852A1/en not_active Withdrawn
-
2013
- 2013-12-20 CN CN201380071345.XA patent/CN104955493A/zh active Pending
- 2013-12-20 PL PL13821692T patent/PL2934612T3/pl unknown
- 2013-12-20 LT LTEP13821692.4T patent/LT2934612T/lt unknown
- 2013-12-20 HU HUE13821692A patent/HUE034649T2/hu unknown
- 2013-12-20 WO PCT/EP2013/077674 patent/WO2014096354A1/en not_active Ceased
- 2013-12-20 ES ES13821692.4T patent/ES2627053T3/es active Active
- 2013-12-20 AU AU2013366544A patent/AU2013366544B2/en not_active Ceased
- 2013-12-20 MX MX2015007625A patent/MX361222B/es active IP Right Grant
- 2013-12-20 PT PT138216924T patent/PT2934612T/pt unknown
- 2013-12-20 HR HRP20170880TT patent/HRP20170880T1/hr unknown
- 2013-12-20 EP EP13821692.4A patent/EP2934612B1/en active Active
- 2013-12-20 SI SI201330670T patent/SI2934612T1/sl unknown
- 2013-12-20 BR BR112015014926A patent/BR112015014926B1/pt not_active IP Right Cessation
- 2013-12-20 US US14/653,862 patent/US20160082145A1/en not_active Abandoned
- 2013-12-20 JP JP2015548630A patent/JP6518591B2/ja not_active Expired - Fee Related
- 2013-12-20 DK DK13821692.4T patent/DK2934612T3/en active
-
2017
- 2017-06-08 CY CY20171100597T patent/CY1118938T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2017100700A3 (en) | Peptides for renal therapy | |
| AR088044A1 (es) | Proteinas de fusion para tratar trastornos metabolicos | |
| EP3501546A3 (de) | Cystein-wirkstoff konjugate und ihre verwendung | |
| AR077764A1 (es) | Polipeptidos selectivos para integrina alfavbeta 3 conjugados a una variante de seroalbumina humana (hsa) y usos farmaceuticos de los mismos | |
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| SG10201803862UA (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
| WO2010048275A3 (en) | Lyophilized recombinant vwf formulations | |
| MX2016006053A (es) | Compuestos selectivos de peptido yy (pyy) y usos de los mismos. | |
| HK1207097A1 (en) | Fusion proteins for treating a metabolic syndrome | |
| WO2014150600A3 (en) | Modified toxins | |
| NZ603200A (en) | Peptides and their use | |
| MX391804B (es) | Proteinas de fusion fgf21 de accion prolongada y composicion farmacuetica que comprende las mismas. | |
| CL2011003003A1 (es) | Composicion tensioactiva reconstituida que comprende un polipeptido análogo a la proteína surfactante c nativa, un polipeptido análogo a la proteína surfactante b nativa, un fosfolipido monoinsaturado y un fosfolipido saturado, útil para el tratamiento del síndrome de dificultad respiratoria. | |
| CL2011000170A1 (es) | Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa. | |
| EP4488289A3 (en) | Long-acting coagulation factors and uses thereof | |
| NZ702801A (en) | Treatment of sanfilippo syndrome type b | |
| WO2014150375A3 (en) | Treatment of collagen defects using protein solutions | |
| WO2012006516A3 (en) | Protein kinase c activators and anticoagulant for the treatment of stroke | |
| HK1216617A1 (zh) | 用人生长激素类似物治疗小儿生长激素缺乏症 | |
| EP2924049A4 (en) | TROPHIC HORMONFUSION PROTEIN, METHOD OF MANUFACTURE AND APPLICATION THEREOF | |
| EA201691008A1 (ru) | 7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2-a]пиридо[3,4-e]пиримидин-5(1h)-он, его соли и способы применения | |
| AR095527A1 (es) | Formulaciones de polipéptido fc-factor ix | |
| EP4275751A3 (en) | Improved naglu fusion protein formulation | |
| JP2010538020A5 (https=) | ||
| MX2016007682A (es) | Composicion farmaceutica que comprende ivabradina amorfa. |